Literature DB >> 15317710

Lens fluorescence and metabolic control in type 1 diabetic patients: a 14 year follow up study.

L Kessel1, B Sander, P Dalgaard, M Larsen.   

Abstract

BACKGROUND/AIMS: In this prospective study the authors followed the post-translational modification of the proteins of the lens of the eye by fluorometry over a period of 14 years in patients with type 1 diabetes mellitus.
METHODS: Twenty patients were examined at 6 years (baseline) and 20 years (follow up) after onset of diabetes mellitus. Glycaemic levels were assessed from HbA1c measured at regular intervals from the onset of diabetes mellitus.
RESULTS: Lens fluorescence at follow up was significantly related to mean HbA1c during the study period and to lens fluorescence at baseline (p<0.0001). Sixty per cent of the variation in rate of increase in lens fluorescence during the study period was statistically attributable to glycaemia levels.
CONCLUSION: The results confirm that the rate of fluorophore accumulation in the lens of adult diabetic patients is increased in proportion to glycaemic control. This parameter alone is, however, not sufficient to explain the entire variation in lens fluorophore accumulation. Consequently, lens fluorescence must be influenced by other factors before initiation and during the study period, and possibly even before onset of diabetes mellitus. The underlying mechanism could be a variation in susceptibility to lens protein denaturation by glycation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15317710      PMCID: PMC1772313          DOI: 10.1136/bjo.2003.028779

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  17 in total

1.  Lens ageing as an indicator of tissue damage associated with smoking and non-enzymatic glycation--a twin study.

Authors:  L Kessel; J L Hougaard; B Sander; K O Kyvik; T I A Sørensen; M Larsen
Journal:  Diabetologia       Date:  2002-09-05       Impact factor: 10.122

2.  Lens autofluorescence in healthy individuals.

Authors:  S Siik; P J Airaksinen; A Tuulonen; H I Alanko; H Nieminen
Journal:  Acta Ophthalmol (Copenh)       Date:  1991-04

3.  Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers.

Authors:  I D Nicholl; A W Stitt; J E Moore; A J Ritchie; D B Archer; R Bucala
Journal:  Mol Med       Date:  1998-09       Impact factor: 6.354

4.  Lens fluorescence in relation to metabolic control of insulin-dependent diabetes mellitus.

Authors:  M Larsen; B Kjer; I Bendtson; P Dalgaard; H Lund-Andersen
Journal:  Arch Ophthalmol       Date:  1989-01

5.  Nonenzymatic browning in vivo: possible process for aging of long-lived proteins.

Authors:  V M Monnier; A Cerami
Journal:  Science       Date:  1981-01-30       Impact factor: 47.728

6.  Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control.

Authors:  L Zhang; G Krzentowski; A Albert; P J Lefebvre
Journal:  Diabetes Care       Date:  2001-07       Impact factor: 19.112

7.  Different risk factors of microangiopathy in patients with type I diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications Study.

Authors:  B Karamanos; M Porta; M Songini; Z Metelko; Z Kerenyi; G Tamas; R Rottiers; L K Stevens; J H Fuller
Journal:  Diabetologia       Date:  2000-03       Impact factor: 10.122

8.  Lens fluorescence in relation to nephropathy in insulin-dependent diabetes mellitus.

Authors:  M Larsen; B Kjer; I Bendtson; P Dalgaard; H Lund-Andersen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

9.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

10.  Lenses of diabetic patients "yellow" at an accelerated rate similar to older normals.

Authors:  M Lutze; G H Bresnick
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-01       Impact factor: 4.799

View more
  6 in total

1.  Simultaneous noninvasive clinical measurement of lens autofluorescence and rayleigh scattering using a fluorescence biomicroscope.

Authors:  John Burd; Stephen Lum; Frederick Cahn; Keith Ignotz
Journal:  J Diabetes Sci Technol       Date:  2012-11-01

2.  Measurement of Lens Autofluorescence Can Distinguish Subjects With Diabetes From Those Without.

Authors:  Frederick Cahn; John Burd; Keith Ignotz; Shardendu Mishra
Journal:  J Diabetes Sci Technol       Date:  2014-01-01

3.  Multiphoton spectral microscopy for imaging and quantification of tissue glycation.

Authors:  Jo-Ya Tseng; Ara A Ghazaryan; Wen Lo; Yang-Fang Chen; Vladimir Hovhannisyan; Shean-Jen Chen; Hsin-Yuan Tan; Chen-Yuan Dong
Journal:  Biomed Opt Express       Date:  2010-12-24       Impact factor: 3.732

4.  The assessment of autofluorescence of the crystalline lens in diabetic patients and healthy controls: can it be used as a screening test?

Authors:  Seren Pehlivanoğlu; Nur Acar; Sinan Albayrak; Muharrem Karakaya; Ali Ofluoğlu
Journal:  Clin Ophthalmol       Date:  2018-06-27

Review 5.  Protein posttranslational modification (PTM) by glycation: Role in lens aging and age-related cataractogenesis.

Authors:  Xingjun Fan; Vincent M Monnier
Journal:  Exp Eye Res       Date:  2021-07-20       Impact factor: 3.770

Review 6.  The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes.

Authors:  Robbert Meerwaldt; Thera Links; Clark Zeebregts; Rene Tio; Jan-Luuk Hillebrands; Andries Smit
Journal:  Cardiovasc Diabetol       Date:  2008-10-07       Impact factor: 9.951

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.